PROCEPT BioRobotics Corp financial data

Symbol
PRCT on Nasdaq
Location
150 Baytech Drive, San Jose, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 5, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 891 % +21.8%
Quick Ratio 121 % +24.2%
Debt-to-equity 33.4 % -30.4%
Return On Equity -21.7 % +43.7%
Return On Assets -16.3 % +37.5%
Operating Margin -30.9 % +42.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 55.9M shares +7.08%
Common Stock, Shares, Outstanding 55.9M shares +7.14%
Entity Public Float 3.1B USD +121%
Common Stock, Value, Issued 0 USD
Weighted Average Number of Shares Outstanding, Basic 55.7M shares +7.15%
Weighted Average Number of Shares Outstanding, Diluted 55.7M shares +7.15%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 300M USD +50.1%
Cost of Revenue 106M USD +24.8%
Research and Development Expense 67.3M USD +9.01%
Operating Income (Loss) -92.5M USD +13.1%
Net Income (Loss) Attributable to Parent -84.6M USD +15.5%
Earnings Per Share, Basic -1 USD/shares +22.1%
Earnings Per Share, Diluted -1 USD/shares +22.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 294M USD +49.6%
Accounts Receivable, after Allowance for Credit Loss, Current 84.5M USD +22.4%
Inventory, Net 66.7M USD +31.2%
Assets, Current 455M USD +40.8%
Property, Plant and Equipment, Net 30M USD +12.8%
Operating Lease, Right-of-Use Asset 17.9M USD -7.07%
Other Assets, Noncurrent 5.1M USD +308%
Assets 512M USD +36.7%
Accounts Payable, Current 11.1M USD -26.3%
Contract with Customer, Liability, Current 10.7M USD +33.5%
Liabilities, Current 53.9M USD +0.47%
Contract with Customer, Liability, Noncurrent 517K USD
Operating Lease, Liability, Noncurrent 25.2M USD -7.81%
Other Liabilities, Noncurrent 576K USD +20.3%
Liabilities 131M USD -1.25%
Accumulated Other Comprehensive Income (Loss), Net of Tax 42K USD
Retained Earnings (Accumulated Deficit) -612M USD -16%
Stockholders' Equity Attributable to Parent 380M USD +57.6%
Liabilities and Equity 512M USD +36.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -17M USD +47.4%
Net Cash Provided by (Used in) Financing Activities 1.3M USD -49.8%
Net Cash Provided by (Used in) Investing Activities -1.84M USD +5.65%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 55.9M shares +7.14%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -17.5M USD +44.6%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 297M USD +48.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 885K USD -11.9%
Deferred Tax Assets, Valuation Allowance 156M USD +28.6%
Deferred Tax Assets, Gross 161M USD +27.2%
Operating Lease, Liability 27.4M USD -6.3%
Payments to Acquire Property, Plant, and Equipment 1.84M USD -5.65%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -84.5M USD +15.5%
Lessee, Operating Lease, Liability, to be Paid 37.6M USD -10.2%
Property, Plant and Equipment, Gross 42.2M USD +26.5%
Operating Lease, Liability, Current 2.14M USD +16.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.81M USD +8.63%
Lessee, Operating Lease, Liability, to be Paid, Year One 4.43M USD +3%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 10.2M USD -19.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 4.95M USD +3%
Deferred Tax Assets, Operating Loss Carryforwards 96.5M USD +20.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 4.72M USD +39.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 5.1M USD +3.01%
Additional Paid in Capital 992M USD +29.1%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 1.48M USD +24.6%
Deferred Tax Assets, Net of Valuation Allowance 4.66M USD -6.09%
Share-based Payment Arrangement, Expense 45.8M USD +65.3%
Interest Expense 4.15M USD -10.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%